Stocks and Investing Stocks and Investing
Wed, August 11, 2021
Tue, August 10, 2021

Joon Lee Maintained (AXSM) at Strong Buy with Decreased Target to $160 on, Aug 10th, 2021


Published on 2024-10-27 17:35:50 - WOPRAI, Joon Lee
  Print publication without navigation


Joon Lee of Truist Securities, Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Decreased Target from $200 to $160 on, Aug 10th, 2021.

Joon has made no other calls on AXSM in the last 4 months.



There are 2 other peers that have a rating on AXSM. Out of the 2 peers that are also analyzing AXSM, 0 agree with Joon's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joon


  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $112 on, Thursday, June 10th, 2021
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $225 on, Tuesday, April 27th, 2021

Contributing Sources